Quotes 5-day view Delayed Nasdaq
222 289 Volume
Net income 2020
Net Debt 2020
P/E ratio 2020
Net income 2021
Net Debt 2021
P/E ratio 2021
Capi. / Sales 2020
Capi. / Sales 2021
Nbr of Employees
Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address the needs of the large and growing facial aesthetics market. It offers physicians and...
Notations Surperformance© of Evolus, Inc.
Trading Rating :
Investor Rating :
All news about EVOLUS, INC.
11/24 EVOLUS, INC. CLASS ACTION ALERT : Wolf Haldenstein Adler Freeman & Herz LLP remi..
11/19 EVOLUS, INC. : Regulation FD Disclosure (form 8-K)
11/14 EVOLUS : ROSEN, A TOP RANKED LAW FIRM, Reminds Evolus, Inc. Investors of Importa..
11/10 SHAREHOLDER ALERT : Robbins LLP Is Investigating Evolus, Inc. (EOLS) on Behalf o..
11/09 DEADLINE REMINDER : Law Offices of Howard G. Smith Reminds Investors of Looming ..
11/05 GLANCY PRONGAY & MURRAY LLP : Reminds Investors of Looming Deadline in the Class..
11/03 EVOLUS : The Law Offices of Frank R. Cruz Announces the Filing of a Securities C..
10/30 EVOLUS : ROSEN, LEADING INVESTOR COUNSEL, Reminds Evolus, Inc. Investors of Impo..
10/30 EVOLUS : Announces Promotion of Michael Mazen Jafar to Chief Commercial Officer ..
10/30 EVOLUS : Reports Third Quarter 2020 Results and Provides Business Update
10/30 EVOLUS, INC. CLASS ACTION ALERT : Wolf Haldenstein Adler Freeman & Herz LLP anno..
10/29 EVOLUS : ROSEN, A TOP RANKED LAW FIRM, Reminds Evolus, Inc. Investors of Importa..
10/29 EVOLUS : Management's Discussion and Analysis of Financial Condition and Results..
10/29 EVOLUS, INC. : Results of Operations and Financial Condition, Change in Director..
10/29 EVOLUS : Announces Promotion of Michael Mazen Jafar to Chief Commercial Officer ..
News in other languages on EVOLUS, INC.
Technical analysis trends EVOLUS, INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Number of Analysts
Average target price
Last Close Price
Spread / Highest target
Spread / Average Target
Spread / Lowest Target